Infectious Disease Alert
RSSArticles
-
Seroreversion in Patients Receiving Antiretrovirals During Early HIV Infection
This paper from the Gladstone Institute at the University of California, San Francisco represents a substudy of intensively studied patients who were enrolled in the Options Project. -
An Emerging Extended-Spectrum Triazole Antifungal: Noxafil® (Posaconazole)
Medical advances in recent years have resulted in an increased frequency of invasive fungal infections.1 Patients undergoing solid organ transplantation, HIV/AIDS treatment, and invasive surgical procedures are especially susceptible to fungal pathogens, and are more likely to experience recurrent fungal infections. -
Pharmacology Watch: GlaxoSmithKline Withdraws Lymerix: Company ‘Cuts Losses’ on Controversial Lyme Disease Vaccine
-
Clinical Briefs in Primary Care Supplement
-
Updates: Can Primary Care MDs Manage TB?; SV-40 in Non-Hodgkins Lymphoma
-
Conference Summaries: ICAAC 2001, IDSA 2001, and ASTMH: Part II
-
Conference Summaries: ICAAC 2001, IDSA 2001, and ASTMH: Part III
-
Clinical Briefs in Primary Care Supplement
-
Updates: A New Flu Peptide with a Purpose?; D4T and Neuromuscular Weakness; Congenital Malaria — Revisited
-
Disease Update: Meningococcal Disease in Pilgrims